Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis.

about

Current perspectives on primary prophylaxis and patient risk factors for venous thromboembolism in the cancer patient.Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.Cerebral embolism and hormone replacement therapy.

P2860

Q36265574-B06032FA-6F8D-422C-9AC3-D423ABBE87CE Q40217071-E93C70EA-714D-4EA4-B622-67F7427660E0 Q43651101-F7EAFD07-3A51-4618-B1CD-6F02244B6FD2

P2860

Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis.

Item

http://www.wikidata.org/entity/Q42538550

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Adjuvant antiestrogen treatmen ...... coagulation and fibrinolysis.

@en

Adjuvant antiestrogen treatmen ...... coagulation and fibrinolysis.

@nl

type

Item

label

Adjuvant antiestrogen treatmen ...... coagulation and fibrinolysis.

@en

Adjuvant antiestrogen treatmen ...... coagulation and fibrinolysis.

@nl

prefLabel

Adjuvant antiestrogen treatmen ...... coagulation and fibrinolysis.

@en

Adjuvant antiestrogen treatmen ...... coagulation and fibrinolysis.

@nl

P1476

Adjuvant antiestrogen treatmen ...... coagulation and fibrinolysis.

@en

P2093

Hoffmann O

http://www.w3.org/2001/XMLSchema#string

Kaiser S

http://www.w3.org/2001/XMLSchema#string

Oberhoff C

http://www.w3.org/2001/XMLSchema#string

Schindler AE

http://www.w3.org/2001/XMLSchema#string

Szymeczek J

http://www.w3.org/2001/XMLSchema#string

Winkler UH

http://www.w3.org/2001/XMLSchema#string

P2860

The protein C anticoagulant system: inherited defects as basis for venous thrombosis

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

Acquired protein S deficiency.

Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women

Disorders of the hemostatic system and the risk of the development of thrombotic and cardiovascular diseases: limitations of laboratory diagnosis.

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.

Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels.

Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group.

Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.

Thrombosis of tibial arteries in a patient receiving tamoxifen therapy.

P2888

a:1006054309066

P304

73-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1023/A:1006054309066

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1998-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1003221128

http://www.w3.org/2001/XMLSchema#string

P698

9802622

http://www.w3.org/2001/XMLSchema#string

Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis.

about

P2860

P2860

Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698